Raphael Underwood

Raphael Underwood
Raphael is a trainee clinical psychologist at the Institute of Psychiatry, Psychology & Neuroscience, King’s College London. He previously completed a PhD at the same institution, looking at cognitive and neural mechanisms underlying maladaptive appraisals in psychosis..

Website

Follow me here –

Long-term outcomes of childhood sexual abuse #ISTSS2019

shutterstock_731750611

Raphael Underwood summarises a recent umbrella review (a synthesis of meta-analyses), which aimed to evaluate the current literature regarding childhood sexual abuse and long-term outcomes (psychosocial outcomes, psychiatric diagnoses and physical health outcomes).

[read the full story...]

Mental health stigma and pathways to care in psychosis

countryside-1835847_1280

Raphael Underwood on a recent systematic review of mental health-related stigma and pathways to care for people at risk of psychotic disorders or experiencing first-episode psychosis.

[read the full story...]

Omega-3 fatty acids to prevent psychosis: the importance of replication (NEURAPRO trial)

22421169767_03c5cce9cf_z

Raphael Underwood summarises the NEURAPRO trial, which concludes that Omega-3 fatty acids are no better than placebo at preventing transition to psychosis in young people at ultrahigh risk for psychotic disorders.

[read the full story...]

Supported employment for people with severe mental illness

5577108264_5d4eb10ae8_o

Raphael Underwood highlights a recent international systematic review of individual placement and support for people with serious mental illness who are seeking to return to work.

[read the full story...]

Group body psychotherapy for negative symptoms of schizophrenia

12264934986_6288d4ee70_k

Raphael Underwood reports on the findings of a recent RCT of group body psychotherapy for negative symptoms of schizophrenia, which finds that body psychotherapy did not have a clinically beneficial effect on reducing emotional withdrawal or improving social functioning.

[read the full story...]

Lithium for schizophrenia: Cochrane find lack of evidence to support its use

8407060410_e06b0d3e09_k

Raphael Underwood presents a new Cochrane review of lithium for schizophrenia, which assesses the use of lithium as a monotherapy and also in combination with antipsychotics.

[read the full story...]

Community treatment orders still don’t work at 36 months: OCTET trial follow up

124733297_cf0c684a8f_o

Raphael Underwood presents the 3 year follow up of the OCTET trial of community treatment orders for people with psychosis, which finds no significant difference on readmission or disengagement for patients on CTOs compared to those discharged to voluntary status via Section 17 leave.

[read the full story...]

Diagnostic test accuracy of first rank symptoms for schizophrenia

shutterstock_220827373

Raphael Underwood summarises a recently updated Cochrane systematic review, which aimed to systematically evaluate the accuracy of first rank symptoms for diagnosing schizophrenia.

[read the full story...]

Joint Crisis Plans: empowering service users with psychotic disorders

shutterstock_223838977

Raphael Underwood reports on a thematic analysis of joint crisis plans, which explores what service users with psychotic disorders want in a mental health crisis or relapse.

[read the full story...]